| abstract |
A compound having the general structure shown in Formula I: n nor pharmaceutically acceptable salt and/or solvates thereof are useful in treating diseases or conditions mediated by NK 1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough. |